Air or Sea: the Verdict
James Strachan |
“There is a growing momentum behind a shift from airfreight to ocean freight (‘modal shift’) as pharma shippers seek to raise quality and lower costs. With the arrival of GDP-compliant small-consignment (LCL) services, with superior insurance arrangements now in place, and with a proven ability for the safe shipment of biologics and high-sensitivity medications, ocean freight should be the automatic default for the long-distance transportation of pharmaceuticals.”
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.